1.Clinical study of Tanshinone ⅡA for treatment on acute cerebral infarction
Journal of Clinical Neurology 1997;0(06):-
Objective To investigate the efficacy and mechanism of Tanshinone ⅡA for treatment on acute cerebral infarction(ACI). Methods 104 patients with ACI were randomly divided into Tanshinone group (50 cases) and control group (54 cases),and were treated with conventional therapy. While,Tanshinone ⅡA was added by intravenous drop in Tanshinone group for 2 weeks. Neurological functional deficit scores,Barthel index(BI) were observed,the levels of serum superoxide dismutas(SOD),lipid peroxide (LPO) and malondialdehyde (MDA) were detected pre and post treatment. The efficacy was compared in the two groups.Results After 2 weeks of treatment,the score of National institute of health stroke scale (NIHSS) was decreased,BI was increased,the level of serum SOD was increased,the levels of serum LPO and MDA were decreased in the two groups. Compared with those in pre treatment,the changes of all the targets were significantly different (all P
2. Application of parametric g-formula in causal analysis
Shilan WU ; Jia ZHOU ; Xun LI ; Linting HUANG ; Jiayue ZHANG ; Chuhao GUO ; Sisi LONG ; Hongzhuan TAN
Chinese Journal of Epidemiology 2019;40(10):1310-1313
At present, traditional methods on statistics have limitations in controlling time- varying confounding. This paper introduces an analysis method, parametric g-formula, which would adjust time-varying confounding, and also exemplifies the steps of its implementation for purpose to provide a new reference for researchers to deal with long-term observational data.